Technical Analysis for ZGNX - Zogenix, Inc.

Grade Last Price % Change Price Change
grade B 46.99 -0.15% -0.07
ZGNX closed down 0.15 percent on Friday, February 15, 2019, on 70 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Mar 5

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ZGNX trend table...

Date Alert Name Type % Chg
Feb 15 Outside Day Range Expansion 0.00%
Feb 15 Overbought Stochastic Strength 0.00%
Feb 14 Slingshot Bullish Bullish Swing Setup -0.15%
Feb 14 Overbought Stochastic Strength -0.15%
Feb 13 Shooting Star Candlestick Bearish -1.53%
Feb 13 Lizard Bearish Bearish Day Trade Setup -1.53%
Feb 13 Doji - Bearish? Reversal -1.53%
Feb 13 Overbought Stochastic Strength -1.53%
Feb 13 Upper Bollinger Band Touch Strength -1.53%
Feb 12 180 Bullish Setup Bullish Swing Setup -0.97%

Older signals for ZGNX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Zogenix, Inc., a pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. Its commercial product includes Sumavel DosePro (sumatriptan injection), a delivery system that offers needle-free subcutaneous administration of sumatriptan for the acute treatment of migraine and cluster headache. The company's lead product candidate, Zohydro, a single-entity extended-release hydrocodone, which has completed Phase III clinical trials for the treatment of moderate to severe chronic pain requiring around-the-clock opioid therapy. It is also developing Relday, an injectable formulation of risperidone, which is in a Phase I clinical trial to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers with 13 years of age and older. Zogenix, Inc. markets and sells its Sumavel DosePro to wholesale pharmaceutical distributors and retail pharmacies in the United States. It has a licensing and distribution agreement with Desitin Arzneimittel GmbH to develop and commercialize DosePro in the European Union, Norway, Switzerland, and Turkey. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was founded in 2006 and is headquartered in San Diego, California.
Chemistry Pharmaceutical Pain Schizophrenia Central Nervous System Disorders Morphinans Neurochemistry Cell Signaling European Union Ketones Migraine Bipolar Disorder Hydrocodone Severe Chronic Pain Treatment Of Central Nervous System Disorders Treatment Of Migraine Indoles Retail Pharmacies Triptans
Is ZGNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 62.75
52 Week Low 33.43
Average Volume 510,638
200-Day Moving Average 44.7805
50-Day Moving Average 42.1138
20-Day Moving Average 44.352
10-Day Moving Average 46.69
Average True Range 1.9164
ADX 29.33
+DI 26.1119
-DI 12.3954
Chandelier Exit (Long, 3 ATRs ) 43.1108
Chandelier Exit (Short, 3 ATRs ) 46.0192
Upper Bollinger Band 49.4609
Lower Bollinger Band 39.2431
Percent B (%b) 0.76
BandWidth 23.037969
MACD Line 1.5802
MACD Signal Line 1.3556
MACD Histogram 0.2246
Fundamentals Value
Market Cap 1.17 Billion
Num Shares 24.8 Million
EPS -3.42
Price-to-Earnings (P/E) Ratio -13.74
Price-to-Sales 35.07
Price-to-Book 12.08
PEG Ratio -0.43
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 49.62
Resistance 3 (R3) 49.70 48.91 49.18
Resistance 2 (R2) 48.91 48.24 48.87 49.03
Resistance 1 (R1) 47.95 47.83 47.56 47.87 48.89
Pivot Point 47.16 47.16 46.96 47.12 47.16
Support 1 (S1) 46.20 46.49 45.81 46.12 45.09
Support 2 (S2) 45.41 46.08 45.37 44.95
Support 3 (S3) 44.45 45.41 44.80
Support 4 (S4) 44.37